Consistent with these studies, we determined that PKM2 knockdown or SKN treatment suppressed migration, invasion, and the expression of IL-1β, IL-6, and IL-8 by TNF-α–treated RA FLSs. The gene discussed is PKM; the disease is rheumatoid arthritis.